Abschluss eines nicht-exklusiven Rabattvertrages gemäß §§ 130a Abs. 8, 130c Abs. 1 SGB V zwischen der IKK classic und der Norgine GmbH zu Xolremdi (R)
TED · 484943-2026Award noticeawardedNo deadline given
Who already wins at this buyer
Firms with recorded awards from IKK classic in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| Bencard Allergie GmbH | 1 | €1 | 2026-05-12 |
| EurimPharm Arzneimittel GmbH | 1 | €1 | 2026-07-06 |
| LEO Pharma GmbH | 1 | €1 | 2026-05-08 |
| Novartis Pharma GmbH | 1 | €1 | 2026-05-28 |
| Swedish Orphan Biovitrum GmbH | 1 | €1 | 2026-05-28 |
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
Abschluss eines nicht-exklusiven Rabattvertrages gemäß §§ 130a Abs. 8, 130c Abs. 1 SGB V zwischen der IKK classic und der Norgine GmbH zu Xolremdi (R) (Wirkstoff: Mavorixafor, ATC-Code: L03AX24), Vertragslaufzeit: 01.09.2026-31.08.2028)
Similar tenders
Closest by meaning — across languages, via embeddings.